Top Markets
Coin of the day
Bellevue Life Sciences Acquisition Corp. Bellevue Life Sciences Acquisition Corp.

Bellevue Life Sciences Acquisition Corp.

BLAC
Rank in Stocks #31352
Bellevue Life Sciences Acquisition Corp. currently does not engage in... Bellevue Life Sciences Acquisition Corp. currently does not engage in substantial operational activities. Its core mission is to orchestrate a business combination, which could manifest as a merger, share exchange, asset acquisition, stock purchase, recapitalization, or reorganization, with one or more enterprises or organizations within the healthcare domain. This firm, established in 2020, maintains its principal office in Bellevue, Washington, and operates as a subordinate entity of Bellevue Global Life Sciences Investors LLC.
Share Price
$3.01
Last synced: 2025-02-14
Market Cap
$13.49M
Change (1 day)
-57.30%
Change (1 year)
0.00%
Country
US
Trade Bellevue Life Sciences Acquisition Corp. (BLAC)
P/B ratio for Bellevue Life Sciences Acquisition Corp. (BLAC)
P/B ratio as of 2026 TTM: 0
According to Bellevue Life Sciences Acquisition Corp. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Bellevue Life Sciences Acquisition Corp. from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors